2025-2034 Antivirals Market Roadmap: Insights for Competitive Advantage

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Antivirals Market Size By 2025?
The market for antivirals has seen robust growth in the past few years. It is expected to rise from $106.64 billion in 2024 to $114.4 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.3%. The expansion in the historical period is due to the incidence of viral diseases, public health worries, patent expiries, and government programs.

How Big Is the Antivirals Market Size Expected to Grow by 2029?
Anticipations point to a robust increase in the size of the antivirals market within the upcoming years. The market is predicted to expand to "$151.54 billion in 2029 with a compound annual growth rate (CAGR) of 7.3%. The surge for the projected period can be credited to emerging viral challenges, worldwide health campaigns. Main trends within the projected period are advancements in technology, the rise in telemedicine and digital health along with personalized medicine.

View the full report here:
https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

Which Key Market Drivers Powering Antivirals Market Expansion and Growth?
The upward trend of influenza cases is projected to spur the antiviral industry's expansion. Influenza, or the flu, is a highly infectious viral affliction of the respiratory system instigated by flu viruses, which impacts the nose, throat, and lungs. Antivirals are applied in influenza therapy and are designed to prevent the replication and proliferation of flu viruses within the human system. For example, in October 2022, the Centers for Disease Control and Prevention, a health agency based in the US, reported that in the 2021-2022 season, there were 9 million cases of flu, 4 million medical visits due to flu, 100,000 hospitalizations because of flu, and 5,000 flu-related deaths. Thus, the escalating frequency of influenza acts as a growth factor for the antiviral sector.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2437&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Antivirals Market?
Key players in the antiviral market are honing their efforts to create ground-breaking treatments like oral antiviral therapies, aiming to enhance patient adherence, accessibility, minimize healthcare costs, and offer more efficient solutions for tackling viral infections. Oral antiviral therapy constitutes medication taken orally to combat viral infections. These remedies operate by obstructing the replication or dispersal of viruses within the human body, consequently alleviating the intensity and span of the infection. For example, in May 2023, US pharmaceutical firm, Pfizer, publicized the sanction of Paxlovid, earning the distinction of the first oral antiviral treatment for COVID-19 in adults approved by the Food and Drug Administration, a US governmental agency. This sanction holds tremendous significance as it introduces a novel therapeutic avenue for managing COVID-19, most notably in a scenario where the pandemic is shifting to more of an endemic phase. Paxlovid is expressly prescribed for adults with mild to moderate COVID-19 that are at substantial risk of escalating to severe disease, including hospitalization or death.

What Are the Emerging Segments in the Antivirals Market?
The antivirals market covered in this report is segmented -

1) By Type: Branded, Generic
2) By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes
3) By Application: HIV, Hepatitis, Herpes, Influenza, Other Applications

Subsegments:
1) By Branded: Antivirals For HIV Or AIDS, Antivirals For Hepatitis, Antivirals For Influenza, Antivirals For Herpes Simplex Virus (HSV)
2) By Generic: Generic HIV Or AIDS Antivirals, Generic Hepatitis Antivirals, Generic Influenza Antivirals, Generic Herpes Simplex Virus (HSV) Antivirals

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2437&type=smp

Who Are the Global Leaders in the Antivirals Market?
Major companies operating in the antivirals market include AbbVie Inc., Bristol-Myers-Squibb Co., Chemical Industrial & Pharmaceutical Laboratories Ltd., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson Services Ltd., Merck & Co. Inc., Dr. Reddy's Laboratories Ltd., AstraZeneca plc, Aurobindo Pharma Ltd., Abbott Laboratories, Schering-Plough Corporation, Pfizer Inc., Sanofi-Synthélabo Ltd., Regeneron Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., Novavax Inc., BioCryst Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Argos Distributors Limited, AVI Biopharma International Ltd., Moderna Inc., BioNTech SE, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Biogen Inc., Genentech USA Inc., Vertex Pharmaceuticals Inc.

Which are the Top Profitable Regional Markets for the Antivirals Industry?
North America was the largest region in the anti-viral drug therapy market in 2024. The Middle East is expected to be the fastest-growing region in the antivirals market during the forecast period. The regions covered in the antivirals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2437

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267
Email:saumyas@tbrc.info
The Business Research Company -www.thebusinessresearchcompany.com
Follow Us On:
LinkedIn:https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.